by
Iwasawa, Ryota
, Sun, Tao
, Yoshioka, Hiroshige
, Alves, Sara
, Spira, Alexander I.
, Lee, Se-Hoon
, Hayashi, Hidetoshi
, Korbenfeld, Ernesto
, Daksh, Mahesh
, Mukhedkar, Sanjay
, How, Soon-Hin
, Gutiérrez Calderón, Vanesa
, Xie, John
, Lee, Jong-Seok
, Lorenzini, Patricia
, Liu, Baogang
, Baig, Mahadi
, Felip, Enriqueta
, Martinez, Melissa
, Califano, Raffaele
, Yang, James C.-H.
, Mourão Dias, Josiane
, Ostapenko, Yurii
, Lu, Shun
, Millington, Dawn
, Vázquez Limón, Juan C.
, Peregudova, Marina
, Ennis, Mariah
, Sethi, Seema
, Cho, Byoung C.
, Cheng, Ying
, Xiong, Hailin
, de Marinis, Filippo
, Thomas, Michael
, Şendur, Mehmet A.N.
, Shah, Sujay
, Alip, Adlinda
, Stroyakovskiy, Daniil
, Lee, Ki-Hyeong
, Chang, Gee-Chen
, Yazici, Ozan
, Leconte, Isabelle
, Besse, Benjamin
, Prabhash, Kumar
, Gadgeel, Shirish M.
, Nguyen, Danny
, Girard, Nicolas
, D’Arcangelo, Manolo
, Knoblauch, Roland E.
, Alatorre-Alexander, Jorge
, Shreeve, S. Martin
, Ou, Sai-Hong I.
, Danchaivijitr, Pongwut
, Bauml, Joshua M.
, Passaro, Antonio
, Fennema, Elizabeth
, Kim, Sang-We
in
Acrylamides - therapeutic use
/ Adult
/ Aged
/ Aged, 80 and over
/ Aniline Compounds - therapeutic use
/ Antibodies, Bispecific
/ Antineoplastic Agents, Immunological - administration & dosage
/ Antineoplastic Agents, Immunological - adverse effects
/ Antineoplastic Combined Chemotherapy Protocols - administration & dosage
/ Antineoplastic Combined Chemotherapy Protocols - adverse effects
/ Antitumor activity
/ Carcinoma, Non-Small-Cell Lung - drug therapy
/ Carcinoma, Non-Small-Cell Lung - genetics
/ Carcinoma, Non-Small-Cell Lung - mortality
/ Carcinoma, Non-Small-Cell Lung - pathology
/ Chemotherapy
/ Confidence intervals
/ Critical Care
/ Critical Care General
/ Epidermal growth factor receptors
/ ErbB Receptors - antagonists & inhibitors
/ ErbB Receptors - genetics
/ Female
/ Hematology
/ Humans
/ Hypotheses
/ Hypothesis testing
/ Kaplan-Meier Estimate
/ Kinases
/ Lung Cancer
/ Lung Neoplasms - drug therapy
/ Lung Neoplasms - genetics
/ Lung Neoplasms - mortality
/ Lung Neoplasms - pathology
/ Magnetic resonance imaging
/ Male
/ Metastases
/ Metastasis
/ Middle Aged
/ Monoclonal antibodies
/ Morpholines - administration & dosage
/ Morpholines - adverse effects
/ Mutation
/ Non-small cell lung carcinoma
/ Oncology
/ Progression-Free Survival
/ Protein Kinase Inhibitors - administration & dosage
/ Protein Kinase Inhibitors - adverse effects
/ Pulmonary
/ Pyrazoles - administration & dosage
/ Pyrazoles - adverse effects
/ Pyrimidines - administration & dosage
/ Pyrimidines - adverse effects
/ Quinolines - therapeutic use
/ Small cell lung carcinoma
/ Statistical analysis
/ Survival analysis
/ Targeted cancer therapy
/ Treatment Outcome
/ Treatments in Oncology
2024
